Harriet Andersén

428 total citations
12 papers, 311 citations indexed

About

Harriet Andersén is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Harriet Andersén has authored 12 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Harriet Andersén's work include Metabolism, Diabetes, and Cancer (3 papers), Pancreatic function and diabetes (3 papers) and Bone health and treatments (2 papers). Harriet Andersén is often cited by papers focused on Metabolism, Diabetes, and Cancer (3 papers), Pancreatic function and diabetes (3 papers) and Bone health and treatments (2 papers). Harriet Andersén collaborates with scholars based in Sweden, United Kingdom and Belgium. Harriet Andersén's co-authors include Mohammad Bohlooly‐Y, David Morgan, Jan Törnell, Claes Ohlsson, Annika Åstrand, Margit Mahlapuu, Xiufeng Xu, Mark H. Rider, Didier Vertommen and Elizabeth C. Cottrell and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Endocrinology and Molecular Pharmacology.

In The Last Decade

Harriet Andersén

12 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harriet Andersén Sweden 12 131 80 67 66 58 12 311
D. Chen Sweden 13 153 1.2× 43 0.5× 67 1.0× 63 1.0× 234 4.0× 19 455
Jude Luzuriaga Australia 8 143 1.1× 35 0.4× 141 2.1× 68 1.0× 245 4.2× 8 443
Daisuke Aotani Japan 11 166 1.3× 110 1.4× 98 1.5× 147 2.2× 67 1.2× 23 422
Larry D. Alexander United States 11 189 1.4× 50 0.6× 71 1.1× 51 0.8× 22 0.4× 18 408
Ajin Lim South Korea 9 258 2.0× 48 0.6× 90 1.3× 141 2.1× 189 3.3× 11 502
Saja Baraghithy Israel 10 125 1.0× 13 0.2× 65 1.0× 60 0.9× 80 1.4× 20 402
Candice Y. Li United States 5 341 2.6× 44 0.6× 64 1.0× 174 2.6× 147 2.5× 6 544
Jiajing Yin China 6 113 0.9× 93 1.2× 43 0.6× 105 1.6× 38 0.7× 7 382
Candice B. Herber United States 9 144 1.1× 40 0.5× 57 0.9× 46 0.7× 15 0.3× 12 375
Nobuaki Takeshita Japan 12 132 1.0× 19 0.2× 22 0.3× 150 2.3× 33 0.6× 28 361

Countries citing papers authored by Harriet Andersén

Since Specialization
Citations

This map shows the geographic impact of Harriet Andersén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harriet Andersén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harriet Andersén more than expected).

Fields of papers citing papers by Harriet Andersén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harriet Andersén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harriet Andersén. The network helps show where Harriet Andersén may publish in the future.

Co-authorship network of co-authors of Harriet Andersén

This figure shows the co-authorship network connecting the top 25 collaborators of Harriet Andersén. A scholar is included among the top collaborators of Harriet Andersén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harriet Andersén. Harriet Andersén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Johanns, Manuel, Gaëtan Herinckx, Didier Vertommen, et al.. (2019). Genetic deletion of soluble 5′-nucleotidase II reduces body weight gain and insulin resistance induced by a high-fat diet. Molecular Genetics and Metabolism. 126(4). 377–387. 14 indexed citations
2.
Vertommen, Didier, Harriet Andersén, Xiufeng Xu, et al.. (2017). Effects of genetic deletion of soluble 5′-nucleotidases NT5C1A and NT5C2 on AMPK activation and nucleotide levels in contracting mouse skeletal muscles. American Journal of Physiology-Endocrinology and Metabolism. 313(1). E48–E62. 23 indexed citations
3.
Lai, Yu‐Chiang, Nadège Zanou, Lars Löfgren, et al.. (2014). Effects of Pharmacological AMP Deaminase Inhibition and Ampd1 Deletion on Nucleotide Levels and AMPK Activation in Contracting Skeletal Muscle. Chemistry & Biology. 21(11). 1497–1510. 35 indexed citations
4.
Laing, Naomi, Shenghua Wen, David C.H. Yang, et al.. (2013). Inhibition of Platelet-Derived Growth Factor Receptor α by MEDI-575 Reduces Tumor Growth and Stromal Fibroblast Content in a Model of Non-Small Cell Lung Cancer. Molecular Pharmacology. 83(6). 1247–1256. 14 indexed citations
5.
Harno, Erika, Elizabeth C. Cottrell, Alice Yu, et al.. (2013). 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitors Still Improve Metabolic Phenotype in Male 11β-HSD1 Knockout Mice Suggesting Off-Target Mechanisms. Endocrinology. 154(12). 4580–4593. 27 indexed citations
6.
Harno, Erika, Elizabeth C. Cottrell, Brian Keevil, et al.. (2013). 11-Dehydrocorticosterone Causes Metabolic Syndrome, Which Is Prevented when 11β-HSD1 Is Knocked Out in Livers of Male Mice. Endocrinology. 154(10). 3599–3609. 29 indexed citations
7.
Black, Dennis M., John P. Bilezikian, S. L. Greenspan, et al.. (2012). Improved adherence with PTH(1–84) in an extension trial for 24 months results in enhanced BMD gains in the treatment of postmenopausal women with osteoporosis. Osteoporosis International. 24(4). 1503–1511. 11 indexed citations
8.
Hu, Lijuan, Kenneth B. Jonsson, Harriet Andersén, et al.. (2011). Over-expression of Adamts1 in mice alters bone mineral density. Journal of Bone and Mineral Metabolism. 30(3). 304–311. 11 indexed citations
9.
Quesada‐Gómez, José Manuel, et al.. (2010). The effect of PTH(1–84) or strontium ranelate on bone formation markers in postmenopausal women with primary osteoporosis: results of a randomized, open-label clinical trial. Osteoporosis International. 22(9). 2529–2537. 18 indexed citations
10.
Hessvik, Nina P., Mark V. Boekschoten, Sander Kersten, et al.. (2009). LXRβ is the dominant LXR subtype in skeletal muscle regulating lipogenesis and cholesterol efflux. American Journal of Physiology-Endocrinology and Metabolism. 298(3). E602–E613. 29 indexed citations
11.
Åstrand, Annika, Mohammad Bohlooly‐Y, Margit Mahlapuu, et al.. (2004). Mice lacking melanin-concentrating hormone receptor 1 demonstrate increased heart rate associated with altered autonomic activity. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 287(4). R749–R758. 71 indexed citations
12.
Bohlooly‐Y, Mohammad, Margit Mahlapuu, Harriet Andersén, et al.. (2004). Osteoporosis in MCHR1-deficient mice. Biochemical and Biophysical Research Communications. 318(4). 964–969. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026